Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg

European Journal of Heart Failure

Volumn 10, Issue 9, 2008, Pages 892-898

  Juhlin, Tord ^a   Jönsson, Bo A G ^a   Höglund, Peter ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACE inhibition; Aspirin; Clinical trial; Heart failure; RAAS; Renal function

Indexed keywords

ACETYLSALICYLIC ACID; BENDROFLUMETHIAZIDE; BROMHEXINE; ENALAPRIL; PLACEBO; TROMBYL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG TOLERABILITY; FEMALE; FREE WATER CLEARANCE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; MALE; MICTURITION; NORMAL HUMAN; OSMOLALITY; POTASSIUM EXCRETION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 51349098212     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.06.014     Document Type: Article

References (35)

1. Awtry E.H., and Loscalzo J. Aspirin. Circulation 101 (2000) 1206-1218
2. Fitzgerald G.A., Oates J.A., Hawiger J., et al. Endogenous biosynthesis of prostacycline and thromboxane and platelet function during chronic administration of aspirin in men. J Clin Invest 71 (1983) 676-688
3. Lonn E.M., Yusuf S., Jha P., et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 90 (1994) 2056-2069
4. The Heart Outcomes Prevention and Evaluation Investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
5. Blais Jr. C., Drapeau G., Raymond P., et al. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study. Am J Physiol 273 (1997) H2263-2H271
6. Parmley W.W. Pathophysiology of congestive heart failure. Am J Cardiol 56 (1985) 7A-711
7. Nguyen K.N., Aursnes I., and Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II. Am J Cardiol 79 (1997) 115-119
8. Al-Khadra A.S., Salem D.N., Rand W.M., Udelson J.E., Smith J.J., and Konstam M.A. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol 31 (1998) 419-425
9. Cleland J.G., Bulpitt C.J., Falk R.H., et al. Is aspirin safe for patients with heart failure?. Br Heart J 74 (1995) 215-219
10. Hall D. Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?. Cardiol Clin 19 (2001) 597-603
11. Cleland J.G.F. Is aspirin "The Weakest Link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease. Prog Cardiovasc Dis 44 (2002) 275-292
12. Juhlin T., Björkman S., Gunnarsson B., Fyge Å., Roth B., and Höglund P. Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors. Eur J Heart Fail 6 (2004) 909-916
13. Guazzi M., Brambilla R., Rèina G., Tumminello G., and Guazzi M.D. Aspirin-angiotensin-converting-enzyme inhibitor coadministration and mortality in patients with heart failure. Arch Intern Med 163 (2003) 1574-1579
14. Stys T., Lawson W.E., Smaldone G.C., and Stys A. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure. Arch Intern Med 160 (2000) 1409-1413
15. Juhlin T., Björkman S., and Höglund P. Cyclooxygenase inhibition causes marked impairment of renal function in elderly treated with diuretics and ACE-inhibitors. Eur J Heart Fail 6 (2005) 1049-1056
16. Juhlin T., Erhardt L.R., Ottosson H., Jönsson B.A.G., and Höglund P. Treatments with losartan or enalapril are equally sensitive to renal deterioration from cyclooxygenase inhibition. Eur J Heart Fail 9 (2007) 191-196
17. Krivosikova Z., Spustova V., and Dzurik R. A highly sensitive HPLC method for simultaneous determination of acetylsalicylic, salicylic, and salicyluric acids in biological fluids; pharmacokinetic, metabolic and monitoring implications. Methods Find Exp Clin Pharmacol 18 (1996) 527-532
18. Kinn A.C., Elbarouni J., Seideman P., and Sollevi A. The effect of diclofenac sodium on renal function. Scand J Urol Nephrol 23 (1989) 153-157
19. Cleland J.G.F., Findlay I., Jafri S., et al. The Warfarin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148 (2004) 157-164
20. Harjai K.J., Nunez E., Turgut T., and Newman J. Effect of combined aspirin and angiotensin-converting enzyme therapy versus angiotensin-converting enzyme therapy alone on readmission rates in heart failure. Am J Cardiol 87 (2001) 483-487
21. Cleland J.G., Ghosh J., Freemantle N., et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 6 (2004) 501-508
22. Hall D., Zeitler H., and Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 20 (1992) 1549-1555
23. Spaulding C., Charbonnier B., Cohen-Solal A., et al. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. Circulation 98 (1998) 757-765
24. van Wijngaarden J., Smit A.J., de Graeff P.A., et al. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 23 (1994) 240-245
25. Meune C., Mahé I., Mourad J.J., et al. Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. Eur J Heart Fail 5 (2003) 271-279
26. MacIntyre I.M., Jhund P.S., and McMurray J.J.V. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure. Cardiovasc Drugs Ther 19 (2005) 261-265
27. Guazzi M., Marenzi G., Alimento M., Contini M., and Agostini P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 95 (1997) 1930-1936
28. Guazzi M., Pontone G., and Agostoni P. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors. Am Heart J 138 (1999) 254-260
29. Kindsvater S., Leclerc K., and Ward J. Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors. Am J Cardiol 91 (2003) 1350-1352
30. Meune C., Wahbi K., Fulla Y., et al. Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors. Eur J Heart Fail 9 (2007) 197-201
31. Guazzi M.D., Campodonico J., Celeste F., et al. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther 63 (1998) 79-86
32. Riegger G.A., Kahles H.W., Elsner D., Kromer E.P., and Kochsiek K. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure. Am J Med 90 (1991) 571-575
33. Davie A.P., Love M.P., and McMurray J.J. Even low-dose aspirin inhibits arachidonic acid-induced vasodilatation in heart failure. Clin Pharmacol Ther 67 (2000) 530-537
34. Pedone C., Cecchi C., Matucci R., Pahor M., Carosella L., Bernabei R., and Mugelli A. Does aspirin attenuate the beneficial effect of ACE-inhibitors in elderly people with heart failure?. Drugs Aging 22 (2005) 605-614
35. McAlister F.A., Ghali W.A., Gong Y., Fang J., Armstrong P.W., and Tu J.V. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation 22 (2006) 2566-2568